Product News
FDA Grants Fast Track Designation to SonALAsense’s SONALA-001
Encouraging preliminary data from the ongoing DIPG clinical study to be presented at the 2023 Society for Neuro-Oncology Annual Meeting in Vancouver.
Product News
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
Product News
Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds
Armis Biopharma, Inc. announced that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product.
Product News
Modelling Enables Breakthroughs in Neuromuscular Disease Research
A team of scientists have developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model Motor Neuron Diseases (MND’s).
Product News
PharmaKure Submits Mhra CTA for Phase 2a Clinical Trial of PK051 in Patients With Mild Cognitive Impairment
Clinical Trial Application filed for combined drug targeting amyloid deposits associated with Alzheimer’s Disease.
Product News
Optibrium Introduces Cloud-Based Version of StarDrop Drug Discovery Platform
Optibrium, announced that its drug discovery platform, StarDrop, is now also available in the cloud environment.
Advertisement
